C19orf45 antibody
Principal name
C19orf45 antibody
Alternative names for C19orf45 antibody
Uncharacterized protein C19orf45
SwissProt ID
Q8NA69 (Human)
Gene ID
374877 (C19orf45)
Ncbi ID
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of C19orf45 antibody
- Kit Component:
- - KN206652G1, C19orf45 gRNA vector 1 in pCas-Guide vector
- KN206652G2, C19orf45 gRNA vector 2 in pCas-Guide vector
- KN206652D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Transfected 293T; WB Suggested Anti-C19orf45 Antibody Titration: 0.2-1 ug/ml. Positive Control: Transfected 293T; C19orf45 antibody - middle region (ARP55899_P050) in Transfected 293T cells using Western Blot
WB Suggested Anti-C19orf45 Antibody Titration: 0.2-1 ug/ml; Positive Control: Transfected 293T
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC229256L2V | Lenti ORF particles, C19orf45 (mGFP-tagged)-Human chromosome 19 open reading frame 45 (C19orf45), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€1,082.00
|
|
| OriGene Technologies, Inc. | ||
| RC229256L1V | Lenti ORF particles, C19orf45 (Myc-DDK-tagged)-Human chromosome 19 open reading frame 45 (C19orf45), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€969.00
|
|
| OriGene Technologies, Inc. | ||
